Quote
—
—
No scored catalysts in the window yet.
Market cap
—
P/E
—
EPS
—
Beta
—
52W range
—
Day range
—
Open
—
Prev close
—
Volume
—
Avg volume
—
Dividend
—
IPO
—
https://www.newsfilecorp.com/release/306143/Hemostemix-Grants-Stock-Options · 7/22/2026+0.10
https://www.newsfilecorp.com/release/302991/Hemostemix-Closes-360000-First-Tranche-of-Private-Placement · 6/26/2026+0.40
https://www.newsfilecorp.com/release/278867/Hemostemix-Appoints-Dr.-David-B.-Alper-to-Lead-Multidisciplinary-Physician-Education-in-the-Use-of-ACP01 · 12/23/2025+0.60
https://www.newsfilecorp.com/release/277583/Hemostemix-Inc.-Announces-FDA-PreIND-Meeting-and-NBPP-of-960000 · 12/10/2025+0.80
https://www.newsfilecorp.com/release/276108/Hemostemix-Starts-its-Rollup-of-Cardiology-Practices-Acquiring-its-First-Two · 11/26/2025+1.00
https://www.newsfilecorp.com/release/271450/Hemostemix-Granted-Trademark-KNOW-YOUR-HEALTH-in-Japan-International-Registration-No.-1744775-Covers-Stem-Cell-Preparations-and-Research-in-Classes-1-5-42 · 10/22/2025+0.60
https://www.newsfilecorp.com/release/269463/Hemostemixs-Insider-Lead-Order-of-330000-Private-Placement · 10/7/2025+0.40
https://www.newsfilecorp.com/release/264944/Howies-17-Years-After-VesCellTM-Following-Hemostemixs-Heart-Patients · 9/3/2025+1.00
https://www.newsfilecorp.com/release/262494/Hemostemixs-Expands-its-Marketing-Team-Focused-on-Sales-in-Florida · 8/14/2025+0.80
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works